DermaNest develops the business of International Personalized Cosmetics Solutions and Services for the US Markets.
Personalized Solutions include Predictive Diagnostics, Therapies and Companion Diagnostics, and DermaNest includes wound-care.
DermaNest's business model and highly experienced team empower early state companies to play in high growth market segments, at a fraction of the cost of alternative solutions.
EXO Labs launches a ruggedized microscope Camera that leverages the iPad platform ( with a "free" App) as a control system and image management tool, targeting the K-12 & Higher Education and Lab needs. This $496 Digital Camera (and App) is a plug and play accessory to any microscope and iPad device. We think this is highly priced (when compared to an iPad or School Microscope), but that is probably going to go down with adoption and volume.
There is a very little technology gap to bridge and expand to Skin or Wound Imaging, and that is why we wanted to quote this system on our Blog.
Out of Israel, DermaCompare, a market-centric spin off from Esmeral Medical, is promoting a Cloud-based sophisticated image processing technology fro skin imaging. The skin lesions detection software solution is designed to revolutionize the process of diagnosing melanoma, the major cause of skin cancer related mortality. DermaCompare supports early stage diagnosis of skin cancer by providing constant monitoring of suspicious skin lesions using various imaging methods, thereby significantly increasing the chances of treating the condition, as well as lowering the cost and complexity of treatment. The product is not FDA approved and detailed information / case studies / performance of the system is not very accessible. We would love to know more ( leave a comment). Their YouTube clip provides some fuzzy screen captures, some insights on the technology platform ( " we use aerial defense technology to save 420 million people from skin cancer") but does not discuss clinical efficacy nor business models.